Guoping Feng and Michael Halassa create mice with global or thalamic-specific loss of the ASD-risk gene PTCHD1 to show specific roles for thalamic PTCHD1 in ASD-like behaviors.
Using SHANK3 conditional knock-in mice, Guoping Feng shows that adult re-expression of SHANK3 improves cellular and behavioral abnormalities, including ASD-like deficits.
SFARI is pleased to announce that it has awarded 28 grants (15 Pilot Awards and 13 Research Awards) in response to the 2015 Pilot and Research Awards request for applications.
On February 6–7, 2020, SFARI convened a two-day workshop to explore the possibility of gene therapies for autism spectrum disorder.
Michael Halassa, Guoping Feng and colleagues identified a combinatorial strategy to reverse noise hypersensitivity in Ptchd1 knockout mice, while Stephen Scherer, James Ellis and colleagues separately explored the genetic and functional complexity of PTCHD1 in humans.
Six current and former SFARI Investigators are among the 213 newly elected members of the American Academy of Arts & Sciences, one of the nation’s oldest and most prestigious honorary societies.
Two SFARI Investigators are among the 84 newly elected members of the National Academy of Sciences.
SFARI announces that it has awarded six grants in response to the Genomic Analysis for Autism Risk Variants in SPARK request for applications. These grants will help to advance the understanding of the genetic basis of autism spectrum disorder.
Yufeng Cheng, Wendy Chung, Chang “April” Shu and their colleagues used machine-learning models to develop a method for large-scale studies to estimate cognitive ability in individuals with autism for whom formal IQ tests are not available.
This year’s new cohort of National Academy of Medicine members includes two investigators funded by the Simons Foundation Autism Research Initiative (SFARI). Election to the academy “recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.”
- Previous Page
- Viewing
- Next Page